Remove 2018 Remove Complication Remove Consulting Remove Illness
article thumbnail

Diabetes in Late Life: Nadine Carter, Tamryn Gray, Alex Lee

GeriPal

When I’m on palliative care consults and attending in our hospice unit we have to counsel patients about deprescribing and de-intensifying diabetes medications. Our last podcast was with Laura Petrillo in 2018 – 5 years ago seems ancient history – though many of the points still apply today (e.g. Goldilocks zone).

article thumbnail

Medical Cannabis Revisted: A Podcast with David Casarett and Eloise Theisen

GeriPal

Summary Transcript CME Summary Cannabis is complicated. Alex 00:30 And we are also delighted to welcome Eloise Theisen, who’s a palliative care nurse practitioner at Stanford and CEO and co- c ounder of Radical Health Clinician Network, which helps patients use cannabis to treat chronic and age related illness.

Medical 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Palliative Care in India: M.R. Rajagopal

GeriPal

When we think about palliative care delivered here, like individuals with chronic pain, non-serious illness chronic pain, non-life threatening illness, oftentimes if we get consulted on them, we don’t even see them, may just be discontinued in most palliative care places. What do you think about that?

Community 115
article thumbnail

Should We Shift from Advance Care Planning to Serious Illness Communication?

GeriPal

Juliet and Rachelle are two of the authors of a recent JAMA viewpoint titled “Shifting to Serious Illness Communication.” . Also see the image below from Alex’s editorial in JAGS , a Venn diagram of advance care planning and serious illness communication. Shifting to Serious Illness Communication. Transcript. What is it?

Illness 98
article thumbnail

‘Not Accountable to Anyone’: As Insurers Issue Denials, Some Patients Run Out of Options

Physician's Weekly

The Right to Try Act, signed by President Donald Trump in 2018, entitles patients with terminal illnesses to try experimental drugs, but it does not obligate insurance companies to pay for them. The cause of his illness remains unknown. But Schrift’s insurance company refused to pay.